載入...
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
BACKGROUND: Over 20 % of ovarian cancer patients have preoperative thrombocytosis or hyperfibrinogenemia. We aimed to demonstrate the clinical and prognostic significance of thrombocytosis and hyperfibrinogenemia in high-grade serous ovarian cancer (HGSC). METHODS: We retrospectively investigated HG...
Na minha lista:
發表在: | BMC Cancer |
---|---|
Main Authors: | , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4730624/ https://ncbi.nlm.nih.gov/pubmed/26817451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2070-2 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|